Ann: Clinical Study in Australia and Webcast, page-30

Just for example.

1000 MRI x 3 tests per day x 260 days per year x $US 1250 per test = $US 975m revenue x 80% profit margin *assume same per magsense / 0.65 AUD = $A 1.2 B profit. Now split that up, the hospitals will want to either charge a premium on top of the 1250, or get a slice of that. Either way, BIG numbers.

What about 2000 MRI ?

And you can start to see why the success case is Mt Everest.
Some will argue the time to roll out, etc, but when it comes to a take over , the big companies dont care if its 2 years, or 5 years.

Its about who gets the IP locked in. Big commercial advantage with marketing of early detection / avoid un necessary biopsy. Noting in some cases biopsies will still be required, but good marketing in the cases where you can avoid the need to do so, becomes the preferred front line diagnosis. IMO.

And that means a cat fight, and bidding war potentially.